Moody’s Upgrades Amgen’s Rating Outlook To Positive

Moody’s Investors Service on Friday raised the outlook on Amgen Inc. to positive from stable and affirmed its A3 long-term rating – MW

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.